SYNEOS HEALTH NORWAY AS

Keywords

researchdevelopment workbiotechnologygenomicspharmageneticsgene samplesdna sequencingdna synthesisdna deepeninggenetic engineeringproteinsmoleculespeptide sequencinglipidglycotechniqueproteomicshormonesgrowth factorscell receptorspheromonescell culturetissue culturecrossingcell fusionvaccineimmunostimulatorsembryo manipulationprocess biotechnologybioreactorsfermentationbioprocessingbiorecoverybiodesulfurizationbiological pulp productionbiofiltrationbiological regenerationsubcellular organismsgene therapyvirusesvectors

Organization

Chairman of the board: MT
Marko Tapani Makkonen1976
Years since formation: 5 years; since Jun 13, 2020
Type: Limited company
VAT registered: Yes
Number of employees: 8

Ownership

Number of shares and share classes: 30,000; 1 share class
Total number of shareholders: 1; person

Financials

Total operating income 2023: 14,029,058; NOK
Annual total result 2023: 103,621; NOK
Total equity 2023: 1,347,491; NOK

Last update: Dec 12, 2024

Management

Board

Name	Role	Shares
MT Marko Tapani Makkonen 1976	Chairman	-
NN Nyla Natalie Donna Maria Singh 1963	Board Member	-

Others

Name	Role	Shares
R RSM NORGE AS	Auditor	-
T TMF NORWAY AS	Accountant	-

Last update: Apr 13, 2023

Ownership

Company shareholders

Name	Share class	Total number of shares	Share
HU Health Uk Limited Syneos	Ordinary shares	30,000	100 %

Last update: May 24, 2024

Financials

in NOK

Summary

Year	2023	2022	2021
Total operating income	14,029,058	13,265,878	7,077,046
Annual Total Result	103,621	834,033	283,811
Total assets	3,402,207	4,436,457	1,972,001
Total liabilities	2,054,716	3,192,587	1,562,165
Total equity	1,347,491	1,243,870	409,837

P&L

Year	2023	2022	2021
Total operating income	14,029,058	13,265,878	7,077,046
Total operating costs	13,978,385	12,203,826	6,705,232
Operating result	50,673	1,062,052	371,814
Financial income/costs	83,488	7,025	-7,756
Profit before tax	134,161	1,069,077	364,058
Total tax & extraordinary income/cost	30,540	235,044	80,247
Annual Total Result	103,621	834,033	283,811

Balance overview

Year	2023	2022	2021
Total fixed assets	58,377	62,920	47,191
Total current assets	3,343,830	4,373,537	1,924,811
Total assets	3,402,207	4,436,457	1,972,001
Short term debt	2,054,716	3,191,737	1,562,165
Long term debt	0	850	0
Total liabilities	2,054,716	3,192,587	1,562,165
Contributed capital	30,000	30,000	30,000
Retained earnings	1,317,491	1,213,870	379,837
Total equity	1,347,491	1,243,870	409,837
Total equity and liabilities	3,402,207	4,436,457	1,972,001

SYNEOS HEALTH NORWAY AS925 041 572